• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

WDHD1 在鼻咽癌中过表达,可能控制 ITGAV 的表达。

WDHD1 is over-expressed in nasopharyngeal carcinoma and may control the expression of ITGAV.

机构信息

Department of Radiotherapy, First Affiliated Hospital of Guangxi Medical University, Nanning, China.

Department of Radiotherapy, Guangxi Medical University Cancer Hospital, Nanning, China.

出版信息

FEBS Open Bio. 2023 Jan;13(1):102-117. doi: 10.1002/2211-5463.13519. Epub 2022 Nov 28.

DOI:10.1002/2211-5463.13519
PMID:36345604
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9811654/
Abstract

Nasopharyngeal carcinoma (NPC) is a highly metastatic and invasive malignant tumor that originates in the nasopharynx. The DNA-binding protein WD repeat and HMG-box DNA-binding protein 1 (WDHD1) are highly expressed in a variety of tumours, but its expression and mechanism of action in NPC have not been reported to date. To investigate the involvement of WDHD1 in NPC, we first mined databases for the gene expression profile of NPC. Immunohistochemistry (IHC) was performed on 338 cases of NPC and 112 non-NPC samples to verify the results. We report that the expression of WDHD1 is significantly elevated in NPC. ChIP-seq was used to show that integrin alpha V (ITGAV) and WDHD1 exhibit a significant binding peak in the promoter region of the ITGAV gene. The expression levels of ITGAV and WDHD1 exhibit a significant positive correlation, and IHC was performed to show that ITGAV is highly expressed in NPC. Expression of ITGAV increased after overexpression of WDHD1, suggesting that ITGAV may be a potential target gene of WDHD1. Pathway analysis showed that both genes were closely related to the cell cycle, and flow cytometry was used to further confirm that decreased expression of WDHD1 significantly increased the number of apoptotic cells. In conclusion, our results suggest that expression of WDHD1 is increased in NPC and is likely to be associated with the NPC cell cycle; thus, we propose that WDHD1 may have the potential as a target gene for primary screening and treatment of NPC.

摘要

鼻咽癌(NPC)是一种高度转移性和侵袭性的恶性肿瘤,起源于鼻咽部。DNA 结合蛋白 WD 重复和 HMG 盒 DNA 结合蛋白 1(WDHD1)在多种肿瘤中高表达,但迄今为止尚未报道其在 NPC 中的表达及其作用机制。为了研究 WDHD1 在 NPC 中的作用,我们首先从数据库中挖掘 NPC 的基因表达谱。对 338 例 NPC 和 112 例非 NPC 样本进行免疫组织化学(IHC)验证。我们报告 WDHD1 在 NPC 中表达明显上调。ChIP-seq 显示整合素 alpha V(ITGAV)和 WDHD1 在 ITGAV 基因启动子区域表现出显著的结合峰。ITGAV 和 WDHD1 的表达水平呈显著正相关,IHC 显示 ITGAV 在 NPC 中高表达。过表达 WDHD1 后 ITGAV 的表达增加,表明 ITGAV 可能是 WDHD1 的潜在靶基因。通路分析表明,两个基因都与细胞周期密切相关,流式细胞术进一步证实,WDHD1 的表达降低显著增加了凋亡细胞的数量。总之,我们的结果表明,WDHD1 在 NPC 中表达增加,可能与 NPC 细胞周期有关;因此,我们提出 WDHD1 可能具有作为 NPC 初筛和治疗的靶基因的潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e7c/9811654/3b1fab7e6767/FEB4-13-102-g013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e7c/9811654/cd76fe3f4ec3/FEB4-13-102-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e7c/9811654/6e342a2f84f7/FEB4-13-102-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e7c/9811654/0ae4615bbf5d/FEB4-13-102-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e7c/9811654/d99fb11fcb75/FEB4-13-102-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e7c/9811654/e5403e89a979/FEB4-13-102-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e7c/9811654/2bbb40e346f5/FEB4-13-102-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e7c/9811654/c91c0e29bcdc/FEB4-13-102-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e7c/9811654/8d36e4973e09/FEB4-13-102-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e7c/9811654/3b4481be2ba3/FEB4-13-102-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e7c/9811654/8210d9d65852/FEB4-13-102-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e7c/9811654/dce4422d5ae7/FEB4-13-102-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e7c/9811654/3b1fab7e6767/FEB4-13-102-g013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e7c/9811654/cd76fe3f4ec3/FEB4-13-102-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e7c/9811654/6e342a2f84f7/FEB4-13-102-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e7c/9811654/0ae4615bbf5d/FEB4-13-102-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e7c/9811654/d99fb11fcb75/FEB4-13-102-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e7c/9811654/e5403e89a979/FEB4-13-102-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e7c/9811654/2bbb40e346f5/FEB4-13-102-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e7c/9811654/c91c0e29bcdc/FEB4-13-102-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e7c/9811654/8d36e4973e09/FEB4-13-102-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e7c/9811654/3b4481be2ba3/FEB4-13-102-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e7c/9811654/8210d9d65852/FEB4-13-102-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e7c/9811654/dce4422d5ae7/FEB4-13-102-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e7c/9811654/3b1fab7e6767/FEB4-13-102-g013.jpg

相似文献

1
WDHD1 is over-expressed in nasopharyngeal carcinoma and may control the expression of ITGAV.WDHD1 在鼻咽癌中过表达,可能控制 ITGAV 的表达。
FEBS Open Bio. 2023 Jan;13(1):102-117. doi: 10.1002/2211-5463.13519. Epub 2022 Nov 28.
2
The clinical significance of transcription factor WD repeat and HMG-box DNA binding protein 1 in laryngeal squamous cell carcinoma and its potential molecular mechanism.转录因子 WD 重复和 HMG 盒 DNA 结合蛋白 1 在喉鳞状细胞癌中的临床意义及其潜在的分子机制。
Pathol Res Pract. 2022 Feb;230:153751. doi: 10.1016/j.prp.2021.153751. Epub 2021 Dec 23.
3
Elevation of MiR-9-3p suppresses the epithelial-mesenchymal transition of nasopharyngeal carcinoma cells via down-regulating FN1, ITGB1 and ITGAV.MiR-9-3p的上调通过下调FN1、ITGB1和ITGAV抑制鼻咽癌细胞的上皮-间质转化。
Cancer Biol Ther. 2017 Jun 3;18(6):414-424. doi: 10.1080/15384047.2017.1323585. Epub 2017 Jun 14.
4
Overexpression of integrin αv in the human nasopharyngeal carcinoma associated with metastasis and progression.整合素αv在人鼻咽癌中的过表达与转移和进展相关。
Cancer Biomark. 2013;13(5):323-8. doi: 10.3233/CBM-130361.
5
Over-expression of BCAT1, a c-Myc target gene, induces cell proliferation, migration and invasion in nasopharyngeal carcinoma.BCAT1 过表达,c-Myc 的靶基因,可诱导鼻咽癌细胞增殖、迁移和侵袭。
Mol Cancer. 2013 Jun 8;12:53. doi: 10.1186/1476-4598-12-53.
6
DNTTIP1 promotes nasopharyngeal carcinoma metastasis via recruiting HDAC1 to DUSP2 promoter and activating ERK signaling pathway.DNTTIP1 通过招募 HDAC1 到 DUSP2 启动子并激活 ERK 信号通路促进鼻咽癌转移。
EBioMedicine. 2022 Jul;81:104100. doi: 10.1016/j.ebiom.2022.104100. Epub 2022 Jun 8.
7
Homeodomain protein DLX4 facilitates nasopharyngeal carcinoma progression via up-regulation of YB-1.同源结构域蛋白 DLX4 通过上调 YB-1 促进鼻咽癌的进展。
Genes Cells. 2020 Jul;25(7):466-474. doi: 10.1111/gtc.12772. Epub 2020 May 11.
8
FLJ10540 is associated with tumor progression in nasopharyngeal carcinomas and contributes to nasopharyngeal cell proliferation, and metastasis via osteopontin/CD44 pathway.FLJ10540 与鼻咽癌的肿瘤进展相关,并通过骨桥蛋白/CD44 途径促进鼻咽癌细胞的增殖和转移。
J Transl Med. 2012 May 16;10:93. doi: 10.1186/1479-5876-10-93.
9
Tubulin polymerization promoting protein family member 3 (TPPP3) overexpression inhibits cell proliferation and invasion in nasopharyngeal carcinoma.微管蛋白聚合促进蛋白家族成员 3(TPPP3)过表达抑制鼻咽癌细胞增殖和侵袭。
Bioengineered. 2021 Dec;12(1):8485-8495. doi: 10.1080/21655979.2021.1984006.
10
FEZF2, a novel 3p14 tumor suppressor gene, represses oncogene EZH2 and MDM2 expression and is frequently methylated in nasopharyngeal carcinoma.FEZF2 是一个新的 3p14 肿瘤抑制基因,可抑制癌基因 EZH2 和 MDM2 的表达,在鼻咽癌中经常发生甲基化。
Carcinogenesis. 2013 Sep;34(9):1984-93. doi: 10.1093/carcin/bgt165. Epub 2013 May 14.

引用本文的文献

1
Machine learning-based identification of exosome-related biomarkers and drugs prediction in nasopharyngeal carcinoma.基于机器学习的鼻咽癌中外泌体相关生物标志物的识别及药物预测
Discov Oncol. 2025 Jun 17;16(1):1134. doi: 10.1007/s12672-025-02962-w.
2
Design, synthesis, and evaluation of novel stilbene derivatives that degrade acidic nucleoplasmic DNA-binding protein 1 (And1) and synergize with PARP1 inhibitor in NSCLC cells.新型二苯乙烯衍生物的设计、合成与评价,该衍生物可降解酸性核浆 DNA 结合蛋白 1(And1),并与 NSCLC 细胞中的 PARP1 抑制剂协同作用。
J Enzyme Inhib Med Chem. 2024 Dec;39(1):2383886. doi: 10.1080/14756366.2024.2383886. Epub 2024 Jul 29.
3

本文引用的文献

1
Targeted inhibition of acidic nucleoplasmic DNA-binding protein 1 enhances radiosensitivity of non-small cell lung cancer.靶向抑制酸性核浆 DNA 结合蛋白 1 增强非小细胞肺癌的放射敏感性。
Cancer Lett. 2022 Apr 1;530:100-109. doi: 10.1016/j.canlet.2022.01.020. Epub 2022 Jan 20.
2
The clinical significance of transcription factor WD repeat and HMG-box DNA binding protein 1 in laryngeal squamous cell carcinoma and its potential molecular mechanism.转录因子 WD 重复和 HMG 盒 DNA 结合蛋白 1 在喉鳞状细胞癌中的临床意义及其潜在的分子机制。
Pathol Res Pract. 2022 Feb;230:153751. doi: 10.1016/j.prp.2021.153751. Epub 2021 Dec 23.
3
Integrative bioinformatics analysis of WDHD1: a potential biomarker for pan-cancer prognosis, diagnosis, and immunotherapy.
WDHD1 的综合生物信息学分析:一种用于泛癌预后、诊断和免疫治疗的潜在生物标志物。
World J Surg Oncol. 2023 Sep 27;21(1):309. doi: 10.1186/s12957-023-03187-3.
4
WD Repeat and HMG Box DNA Binding Protein 1: An Oncoprotein at the Hub of Tumorigenesis and a Novel Therapeutic Target.WD 重复和 HMG 盒 DNA 结合蛋白 1:一种位于肿瘤发生中心的癌蛋白和一个新的治疗靶点。
Int J Mol Sci. 2023 Aug 6;24(15):12494. doi: 10.3390/ijms241512494.
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.
《全球癌症统计数据 2020:全球 185 个国家和地区 36 种癌症的发病率和死亡率估计》。
CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4.
4
STAT3 plays an important role in DNA replication by turning on WDHD1.信号转导及转录激活因子3(STAT3)通过激活WDHD1在DNA复制中发挥重要作用。
Cell Biosci. 2021 Jan 7;11(1):10. doi: 10.1186/s13578-020-00524-x.
5
WDHD1 is essential for the survival of PTEN-inactive triple-negative breast cancer.WDHD1 对于 PTEN 失活的三阴性乳腺癌的存活是必需的。
Cell Death Dis. 2020 Nov 21;11(11):1001. doi: 10.1038/s41419-020-03210-5.
6
The clinical significance of apolipoprotein L1 in head and neck squamous cell carcinoma.载脂蛋白L1在头颈部鳞状细胞癌中的临床意义。
Oncol Lett. 2020 Dec;20(6):377. doi: 10.3892/ol.2020.12240. Epub 2020 Oct 22.
7
Identification of Prognostic miRNA Signature and Lymph Node Metastasis-Related Key Genes in Cervical Cancer.宫颈癌中预后性miRNA特征及淋巴结转移相关关键基因的鉴定
Front Pharmacol. 2020 May 8;11:544. doi: 10.3389/fphar.2020.00544. eCollection 2020.
8
targeting as a therapeutic approach for treatment of metastatic breast cancer.靶向治疗作为转移性乳腺癌的一种治疗方法。
Am J Cancer Res. 2020 Jan 1;10(1):211-223. eCollection 2020.
9
MicroRNA-494-dependent WDHDI inhibition suppresses epithelial-mesenchymal transition, tumor growth and metastasis in cholangiocarcinoma.miRNA-494 依赖性 WDHDi 抑制抑制胆管癌中的上皮-间充质转化、肿瘤生长和转移。
Dig Liver Dis. 2019 Mar;51(3):397-411. doi: 10.1016/j.dld.2018.08.021. Epub 2018 Aug 30.
10
F-box and leucine-rich repeat protein 5 promotes colon cancer progression by modulating PTEN/PI3K/AKT signaling pathway.F-box 和富含亮氨酸重复蛋白 5 通过调节 PTEN/PI3K/AKT 信号通路促进结肠癌的进展。
Biomed Pharmacother. 2018 Nov;107:1712-1719. doi: 10.1016/j.biopha.2018.08.119. Epub 2018 Sep 8.